Baker JR, Mahdi M, Nicolau DV, et al. Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis. Lancet Respir Med 2022; 10: 545–56. We now offer open access for authors based at JISC-participating UK institutions for papers accepted after Jan 1, 2022. As a result, the copyright license for this Article has been updated to CC BY. This correction has been made to the online version as of May 31, 2022, and is correct in the printed version.
. 2022 May 31;10(6):e60. doi: 10.1016/S2213-2600(22)00188-6
Correction to Lancet Respir Med 2022; 10: 545–56
Issue date 2022 Jun.
© 2022 The Author(s). Published by Elsevier Ltd.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9154359 PMID: 35659011